Table 1.
Baseline characteristics of patients receiving MHD
| Variables | Value |
|---|---|
| Age (years) | 51.07 ± 11.65 |
| Gender | |
| Male | 67 (65.05%) |
| Female | 36 (34.95%) |
| Household location | |
| Local | 90 (87.38%) |
| Non-local | 13 (12.62%) |
| Marital status | |
| Married | 67 (65.05%) |
| Single | 36 (34.95%) |
| Raising children | |
| Yes | 88 (85.44%) |
| No | 15 (14.56%) |
| Living alone | |
| Yes | 17 (16.50%) |
| No | 86 (83.50%) |
| Level of Education | |
| Primary school or below | 6 (5.83%) |
| Junior middle school | 36 (34.95%) |
| Senior middle school | 41 (39.81%) |
| University or above | 20 (19.42%) |
| Employment status | |
| Yes | 24 (23.30%) |
| No | 79 (76.70%) |
| Religious beliefs | |
| Yes | 10 (7.71%) |
| No | 93 (90.29%) |
| Primary diseases | |
| Glomerulonephritis | 69 (66.99%) |
| Diabetic nephropathy | 13 (12.62%) |
| Renal vascular disease | 8 (7.76%) |
| Others (e.g., LN, polycystic kidney) | 13 (12.62%) |
| Duration of hemodialysis (months) | 75.55 ± 63.77 |
| Blood pressure level | |
| Systolic pressure (mmHg) | 146.33 ± 24.89 |
| Diastolic pressure (mmHg) | 80.98 ± 15.23 |
| Number of oral medications | |
| < 5 | 35 (33.98%) |
| 5–10 | 56 (54.37%) |
| ≥ 10 | 12 (11.65%) |
| Waiting list status for kidney transplantation | |
| Active | 16 (15.53%) |
| Not active | 87 (84.47%) |
| CCI (mean ± SD) | 3.13 ± 1.82 |
| Vascular access failure during the previous 12 months | |
| Yes | 9 (8.74%) |
| No | 94 (91.26%) |
| Smoking habit | |
| Yes | 26 (25.24%) |
| No | 77 (74.76%) |
| Consumption of alcohol | |
| Yes | 2 (1.94%) |
| No | 101 (98.06%) |
| Participation in social activities | |
| Yes | 5 (4.85%) |
| No | 98 (95.15%) |
| Participation in recreational activities | |
| Yes | 38 (36.89%) |
| No | 65 (63.11%) |
| Travel time to dialysis facilities. | |
| < 30 min | 55 (53.40%) |
| 30-60 min | 20 (19.42%) |
| ≥ 60 min | 28 (27.18%) |
| Laboratory results | |
| Hemoglobin level (g/L) | 108.03 ± 17.18 |
| Serum Calcium level (mmol/L) | 2.32 ± 0.30 |
| Serum Phosphorus level (mmol/L) | 2.15 ± 0.67 |
| Parathyroid hormone level (pg/mL) | 362.57 ± 293.09 |
| Albumin (g/L) | 37.92 ± 3.45 |
| Prealbumin (g/L) | 307.56 ± 78.82 |
| Triglyceride (mmol/L) | 1.90 ± 1.50 |
| Cholesterol (mmol/L) | 3.66 ± 1.18 |
| Dialysis adequacy Kt/V | 1.28 ± 0.25 |
| URR | 65.22 ± 7.07 |
Abbreviations: CCI Charlson comorbidity index, MHD maintenance hemodialysis, SD standard deviation, URR urea reduction ratio. Data are presented as Mean ± SD or n (%)